Incidence of retinopathy of prematurity and risk factors among premature infants at a neonatal intensive care unit in Canada
- PMID: 23205771
- DOI: 10.3928/01913913-20121127-02
Incidence of retinopathy of prematurity and risk factors among premature infants at a neonatal intensive care unit in Canada
Abstract
Purpose: To study the incidence of retinopathy of prematurity (ROP) in a neonatal intensive care unit and obtain information on risk factors associated with ROP.
Methods: Four hundred twenty-three infants were screened for ROP between July 2006 and July 2010. Demographic information, clinical data, and risk factors were reviewed.
Results: The incidence was 40.4% (171 infants) for ROP, 9.2% (39 infants) for severe ROP, and 5.67% (24 infants) for laser treatment. Mean gestational age and birth weight were significantly lower among infants with ROP versus those without ROP (26 ± 0.13 vs 28.55 ± 0.12 weeks, P < .0001 and 840.5 ±17.49 vs 1,190.24 ± 20.20 g, P < .0001, respectively). Birth weight (P < .001), gestational age (P < .001), mechanical ventilation therapy (P = .039), and necrotizing enterocolitis (P = .019) were independent risk factors for ROP.
Conclusion: Gestational age and birth weight were the most significant risk factors for developing ROP. The study population had an elevated percentage of infants with birth weight less than 1,000 g (extremely low birth weight), yet there was no corresponding increase in severe ROP incidence and treatment when compared to other studies.
Copyright 2013, SLACK Incorporated.
Similar articles
-
[Screening analysis of retinopathy of prematurity and treatment of threshold retinopathy of prematurity].Zhonghua Yan Ke Za Zhi. 2006 Jun;42(6):496-500. Zhonghua Yan Ke Za Zhi. 2006. PMID: 16857127 Chinese.
-
Retinopathy of prematurity: are we screening too many babies?Eye (Lond). 2002 Sep;16(5):538-42. doi: 10.1038/sj.eye.6700031. Eye (Lond). 2002. PMID: 12194065
-
Severe retinopathy of prematurity in extremely low birth weight infants after short-term dexamethasone therapy.J Perinatol. 1995 May-Jun;15(3):178-82; quiz 183-4. J Perinatol. 1995. PMID: 7666264
-
Retinopathy of prematurity in Indonesia: Incidence and risk factors.J Neonatal Perinatal Med. 2017;10(1):85-90. doi: 10.3233/NPM-915142. J Neonatal Perinatal Med. 2017. PMID: 28304327 Review.
-
Retinopathy of prematurity-incidence today.Clin Perinatol. 2013 Jun;40(2):185-200. doi: 10.1016/j.clp.2013.02.001. Clin Perinatol. 2013. PMID: 23719304 Review.
Cited by
-
Retinopathy of prematurity: An update on screening and management.Paediatr Child Health. 2016 Mar;21(2):101-8. doi: 10.1093/pch/21.2.101. Paediatr Child Health. 2016. PMID: 27095887 Free PMC article.
-
Association of various postnatal risk factors with progression of retinopathy of prematurity (ROP) in preterm neonates: A case-control study.J Family Med Prim Care. 2025 Apr;14(4):1368-1374. doi: 10.4103/jfmpc.jfmpc_1493_24. Epub 2025 Apr 25. J Family Med Prim Care. 2025. PMID: 40396055 Free PMC article.
-
Incidence and risk factors for retinopathy of prematurity in premature, extremely low birth weight and extremely low gestational age infants.BMC Ophthalmol. 2022 Sep 13;22(1):367. doi: 10.1186/s12886-022-02591-9. BMC Ophthalmol. 2022. PMID: 36096834 Free PMC article.
-
One-year refractive outcomes after intravitreal bevacizumab versus laser photocoagulation for retinopathy of prematurity.Int Ophthalmol. 2023 Jul;43(7):2197-2202. doi: 10.1007/s10792-022-02615-9. Epub 2022 Dec 15. Int Ophthalmol. 2023. PMID: 36522564
-
Anti-vascular Endothelial Growth Factor Treatment of Retinopathy of Prematurity: Efficacy, Safety, and Anatomical Outcomes.Korean J Ophthalmol. 2018 Dec;32(6):451-458. doi: 10.3341/kjo.2018.0011. Korean J Ophthalmol. 2018. PMID: 30549468 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical